The Latest Breaking News from FDA

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

Wall Street looks bullish on Biogen’s (BIIB) prospects after the company’s success during the Phase 3 clinical trial of lecanemab. The drug could boost the company’s financials significantly as it could herald a new era for people with Alzheimer’s disease. Its bright growth prospects have earned it a Strong Buy…

The experimental drug lecanemab was able to slow down Alzheimer's in a large study. Many researchers think the drug will become the first to help large numbers of patients.

Juul Labs has reached settlements covering cases brought by about 10,000 plaintiffs related to its vaping products. Buffeted by lawsuits, Juul announced hundreds of layoffs last month.

First made available in October for adults with mild to moderate hearing loss, they’re cheaper and easier to get. Here’s a guide to who can use them and how to get them.

Insider buying is considered a reliable indicator of a company’s prospects since insiders have the most up-to-date knowledge about the company’s inner workings and its outlook that could be unknown to analysts and investors. Insiders have been buying up shares of Coca-Cola (KO), Biogen (BIIB), and Pure Storage (PSTG) of…

ATLANTA — Earlier this year, top leadership at the Centers for Disease Control and Prevention began a monumental task: turning the sprawling, labyrinthine organization known for its highly specialized, academically focused scientific research into a sleek, flexible public health response agency primed to serve the American public. It’s an attempt…

Electronic cigarette maker Juul Labs has reached settlements covering more than 5,000 cases brought by about 10,000 plaintiffs related to its vaping products

You can’t turn lives and economies off and on without inflicting lingering harm.